Microbiome Report for Week Ending 10/27/18

Microbiome Biotech Enterome and Takeda sign Crohn's Deal Worth Up To $600 Million+ 
Enterome will receive an upfront payment of $50 million end is eligible to receive up to $640 in additional payments